Celyad Oncology is a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies. The Company is focusing on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property and support the development of next-generation CAR T-cell candidates in solid tumors and hematological malignancies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.